Advert - LEO Pharma – AUTH/3311/2/20

• Date posted
  02 August 2021
• Sanction
  Advertisement,
• Case number/s
  AUTH/3311/2/20 - Complainant v Leo

For a media advisory board for Kyntheum (brodalumab) which did not meet the Code requirements and was thus considered to be promotional, LEO Pharma was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.1 - Promoting an unlicensed medicine

Clause 9.1 - Failing to maintain high standards